News
-
-
-
COMMUNIQUÉ DE PRESSE
Jaguar Health Provides Update Regarding Special Stock Dividend
Jaguar Health, Inc. provides update on special stock dividend payout and ex-dividend date for Series R Convertible Preferred Stock. CEO Lisa Conte comments on company's strategic focus and development program for oral crofelemer -
-
-
COMMUNIQUÉ DE PRESSE
Positive Preliminary Results Presented at Annual American College of Gastroenterology Meeting for Open-Label Study in Adult Short Bowel Syndrome Patients with Intestinal Failure (SBS-IF) with Jaguar Health's Crofelemer
Napo Pharmaceuticals presents positive preliminary results for crofelemer powder in Type 1 short bowel syndrome patients at ACG 2026, focusing on reducing ostomy output and improving quality of life -
-
-
COMMUNIQUÉ DE PRESSE
Reminder: Today, October 13, 2026, is the Record Date for Jaguar Health's Special Stock Dividend
Jaguar Health, Inc. announces Special Stock Dividend for Jaguar Common Stock holders on October 13, 2026, with Record and Payment dates set. Company's CEO Lisa Conte shares perspective on rewarding stockholders and ongoing global development program -
